Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2021 Dec;131(12):E2841-E2848.
doi: 10.1002/lary.29760. Epub 2021 Jul 26.

Modeling Recurrence in Idiopathic Subglottic Stenosis With Mobile Peak Expiratory Flow

Collaborators, Affiliations
Observational Study

Modeling Recurrence in Idiopathic Subglottic Stenosis With Mobile Peak Expiratory Flow

Kyle Kimura et al. Laryngoscope. 2021 Dec.

Abstract

Objectives/hypothesis: We sought to establish normative peak expiratory flow (PEF) data for patients with idiopathic subglottic stenosis (iSGS), evaluate whether immediate changes in PEF after a procedure predict long-term treatment response, and test if a decline in longitudinal PEF is associated with disease recurrence.

Study design: International, prospective, 3-year multicenter cohort study of 810 patients with untreated, newly diagnosed, or previously treated iSGS.

Methods: iSGS patients consented and enrolled in the North American Airway Collaborative (NoAAC) iSGS1000 cohort recorded PEF data on a mobile smartphone app. Cox regression tested the associations between the magnitude of postoperative PEF improvement and longitudinal 90-day PEF decline with the risk of disease recurrence.

Results: Within the NoAAC iSGS1000 cohort, 810 patients participated in a 3-year prospective study comparing surgical treatment efficacy and 385 had appropriate PEF measurements and follow-up data. Of those patients, 42% (161/385) required at least one operation during study follow-up. The mean PEF preceding operative intervention was 241 L/min (95% confidence interval [CI]: 120-380) corresponding to a predicted PEF of 52%. The mean increase in PEF following a procedure was 111 L/min (95% CI: 96-125 L/min). Interestingly, the magnitude of immediate PEF improvement was not predictive of disease recurrence (hazard ratio [HR] for 100 L/min increase = 0.90, 95% CI: 0.60-1.00). However, recurrence was associated with the magnitude of PEF decline over 90 days (30% vs. 10% decline, HR = 2.2, 95% CI: 1.5-3.0).

Conclusions: We provide normative PEF data on a large iSGS patient cohort. The degree of PEF improvement immediately after surgery was not associated with a longer procedure-free interval. However, a 30% decline in PEF over 90 days was associated with elevated risk of disease recurrence.

Level of evidence: 2 Laryngoscope, 131:E2841-E2848, 2021.

Keywords: Idiopathic subglottic stenosis; disease-free interval; expiratory flow; peak expiratory flow.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: None.

Figures

Figure 1.
Figure 1.
Patient inclusion flowsheet.
Figure 2.
Figure 2.
A) Distribution of PEFPRE and PEFPOST B) Distributions of relative PEFPRE (% predicted) and PEFPOST. C) Individual treatment responses after surgical procedure for 137 patients with one or more operations after trial enrollment.
Figure 3.
Figure 3.
Kaplan-Meier curves by stratum of ΔPEF (ΔPEF = PEFPOST - PEFPRE) in L/min.
Figure 4.
Figure 4.
Estimated relationship between longitudinal PEF decline and recurrent procedure free survival. The % decline in PEF over 90 days was utilized as a continuous variable in Cox regression analysis estimating probability of operative procedure. Patients with a 30% decline in PEF were more than twice as likely to require an operative procedure when compared with patients that only experienced a 10% decline (HR: 2.2, 95% CI: 1.5–3.0).
Figure 5.
Figure 5.
Predictions of exact PEFNADIR date based on slope derived from different amount of PEF data after a highest PEF (such as after an operation). The y axis represents the difference (in days) between the predicted date of PEFNADIR and observed date of PEFNADIR (the larger the absolute value of the number, the worse the prediction).
Figure 6.
Figure 6.
Distinct patterns of PEF decline in iSGS patients: “sawtooth” (left) andflatline” (right).

References

    1. Gelbard A, Katsantonis N-G, Mizuta M, et al. Idiopathic subglottic stenosis is associated with activation of the inflammatory IL‐17A/IL‐23 axis. Laryngoscope. 2016;126(11):E356–E361. doi:10.1002/lary.26098 - DOI - PMC - PubMed
    1. Morrison RJ, Katsantonis N-G, Motz KM, et al. Pathologic Fibroblasts in Idiopathic Subglottic Stenosis Amplify Local Inflammatory Signals. Otolaryngol Neck Surg. 2019;160(1):107–115. doi:10.1177/0194599818803584 - DOI - PMC - PubMed
    1. Perotin J-M, Jeanfaivre T, Thibout Y, et al. Endoscopic Management of Idiopathic Tracheal Stenosis. Ann Thorac Surg. 2011;92(1):297–301. doi:10.1016/j.athoracsur.2011.03.129 - DOI - PubMed
    1. Nouraei SM, Franco RA, Dowdall JR, et al. Physiology‐based minimum clinically important difference thresholds in adult laryngotracheal stenosis. Laryngoscope. 2014;124(10):2313–2320. doi:10.1002/lary.24641 - DOI - PubMed
    1. Gelbard A, Anderson C, Berry LD, et al. Comparative Treatment Outcomes for Patients With Idiopathic Subglottic Stenosis. JAMA Otolaryngol-- Head Neck Surg. 2019;146(1):1–10. doi:10.1001/jamaoto.2019.3022 - DOI - PMC - PubMed

Publication types